title: Dosimetric comparison of brachytherapy sources for high-dose-rate treatment of endometrial cancer: (192)Ir, (60)Co and an electronic brachytherapy source.
abstract: OBJECTIVE
  To compare high-dose-rate (HDR) brachytherapy systems with (192)Ir, (60)Co and electronic brachytherapy source (EBS) for treatment of endometrial cancers.
  
  
  METHODS
  Two additional plans were generated per patient fraction using a (60)Co source and Xoft-EBS on 10 selected patients, previously treated with a vaginal cylinder applicator using a (192)Ir source. Dose coverage of "PTV_CYLD", a 5-mm shell surrounding the cylinder, was evaluated. Doses to the following organs at risk (OARs) the rectum, bladder and sigmoid were evaluated in terms of V35% and V50%, the percentage volume receiving 35% and 50% of the prescription dose, respectively, and D2cm(3), the highest dose to a 2-cm(3) volume of an OAR.
  
  
  RESULTS
  Xoft-EBS reduces doses to all OARs in the lower dose range, but it does not always provide better sparing of the rectum in higher dose range as does evaluation using D2cm3. V150% and V200% for PTV_CYLD was up to four times greater for Xoft-EBS plans than for plans generated with (192)Ir or (60)Co. Surface mucosal (vaginal cylinder surface) doses were also 23% higher for Xoft-EBS than for (192)Ir or (60)Co plans.
  
  
  CONCLUSIONS
  Xoft-EBS is a suitable HDR source for vaginal applicator treatment with advantages of reducing radiation exposure to OARs in the lower dose range, while simultaneously increasing the vaginal mucosal dose.
  
  
  CONCLUSIONS
  This work presents newer knowledge in dosimetric comparison between (192)Ir or (60)Co and Xoft-EBS sources for endometrial vaginal cylinder HDR planning.
authors.affiliation: 1 Department of Radiation Oncology, University of Mississippi Medical Center, Jackson, MS, USA.|2 Cameroon Oncology Center, Douala, Cameroon.
authors.forename: Paul N
authors.initials: PN
authors.lastname: Mobit
authors.affiliation: 1 Department of Radiation Oncology, University of Mississippi Medical Center, Jackson, MS, USA.
authors.forename: Alex
authors.initials: A
authors.lastname: Nguyen
authors.affiliation: 1 Department of Radiation Oncology, University of Mississippi Medical Center, Jackson, MS, USA.
authors.forename: Satyaseelan
authors.initials: S
authors.lastname: Packianathan
authors.affiliation: 1 Department of Radiation Oncology, University of Mississippi Medical Center, Jackson, MS, USA.
authors.forename: Rui
authors.initials: R
authors.lastname: He
authors.affiliation: 1 Department of Radiation Oncology, University of Mississippi Medical Center, Jackson, MS, USA.
authors.forename: Claus C
authors.initials: CC
authors.lastname: Yang
mesh_terms: D001918:Brachytherapy / Q000379:methods*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D016889:Endometrial Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D007496:Iridium Radioisotopes / Q000627:therapeutic use*; D058958:Organs at Risk; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted
chemical_list: D003037:Cobalt Radioisotopes; D007496:Iridium Radioisotopes